Screening for hepatitis and linked cancers practical and lifesaving, experts say

Publicly released:
New Zealand
Europeana via Unsplash
Europeana via Unsplash

The key factor behind a common type of cancer with a low survival rate is liver disease from chronic hepatitis B or C viral infections—but screening initiatives in Aotearoa could eliminate it within a generation, according to health experts. Seventy percent of hepatocellular carcinoma cases in Māori and 50% of cases in non-Māori are linked with hepatitis B or C. Over two-thirds of such cases in Aotearoa are caught when it's too late to cure. However, the authors of a new review paper say we already have testing and treatment capabilities that, through their proposed detection and treatment programme, could prevent dozens of deaths a year.

Journal/
conference:
Journal of the Royal Society of New Zealand
Research:Paper
Organisation/s: University of Auckland
Funder: N/A
Media Contact/s
Contact details are only visible to registered journalists.